CarlosHBecerraMD

PubMed

• 62 citations
  Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
  Jennifer R. Diamond, Donald A. Richards, Alain C. Mita, Cynthia Osborne, Joyce O'Shaughnessy, Chun Zhang, Randall Henner, Ann M. Kapoun, Lu Xu, Bob Stagg, Shailaja Utt...> ;Breast Cancer Research and Treatment. 2020 Aug 14
• 36 citations
  Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
  , , , , , , , , , , , , , , , , > ;Cancer Chemotherapy and Pharmacology. 2020 Feb 15
• 2 citations
  A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients wit...
  , , , , , , , , , , , , , , , > ;Breast Cancer Research and Treatment. 2019 Jul 31
• 5 citations
  Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
  Muhammad Wasif Saif, Lee S. Rosen, Michelle A. Rudek, Weijing Sun, Dale R. Shepard, Fumiaki Yamashita, Paul Bebeau, Robert Winkler> ;British Journal of Clinical Pharmacology. 2019 Jun 1
• 26 citations
  Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
  Raju Kandimalla, Feng Gao, Takatoshi Matsuyama, Toshiaki Ishikawa, Hiroyuki Uetake, Naoki Takahashi, Yasuhide Yamada, Scott Kopetz, Xin Wang, Ajay Goel> ;Clinical Cancer Research. 2018 Aug 15
• 35 citations
  Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast ca...
  , , , , , , , , , , , , , , , , , , > ;Cancer Chemotherapy and Pharmacology. 2018 Aug 1
• Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors
  , , , , , , , , , , , , , , , > ;Cancer Chemotherapy and Pharmacology. 2016 Sep 28
• 17 citations
  A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers
  Andrew L. Coveler, Andrew H. Ko, Daniel V.T. Catenacci, Daniel D. Von Hoff, Nancy Whiting, Jing Yang, Brian M. Wolpin> ;Investigational New Drugs. 2016 Mar 18
• 45 citations
  Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma
  Daniel Tuse, Nora Ku, Maurizio Bendandi, Carlos Becerra, Robert H. Collins, Nyla Langford, Susana Inoges Sancho, Ascensión López-Díaz de Cerio, Fernando Pastor, Romy K...> ;Biomed Research International. 2015 Sep 6
• Join now to see all